News

12.06.23

IMIDomics and Bristol Myers Squibb Expand Long-Standing Partnership to Advance Immune-Mediated Inflammatory Disease Treatment Research and Development

Read more

11.15.23

IMIDomics Strengthens its Leadership with the Addition of Dr. Eric Perakslis to its Executive Team and Dr. Ramon Felciano to its Advisory Team

Read more

11.02.23

Welcome back to The “i” your go-to source for all things generative AI.

Read more
Tau Motors Wins “Vehicle-to-Everything (V2X) Innovation of the Year” in 2023 AutoTech Breakthrough Awards Program

10.12.23

Tau Motors Wins “Vehicle-to-Everything (V2X) Innovation of the Year” in 2023 AutoTech Breakthrough Awards Program

Read more

09.06.23

IMIDomics Inc. Secures Exclusive Worldwide Licensing Agreement with TNAX Biopharma Corporation for TNAX101A (IMB1001), A Promising Drug Candidate for Immune-Mediated Inflammatory Diseases | Business Wire

Read more
An Electrifying Collaboration: From the Lab to the Marketplace

08.02.23

An Electrifying Collaboration: From the Lab to the Marketplace

Read more

07.17.23

Welcome back to The “i” your go-to source for all things generative AI.

Read more

07.13.23

Tau Motors Named to Fast Company’s 2023 List of the 100 Best Workplaces for Innovators and Earns Top Honors as the Winner of the Small Companies (Under 100 Employees) Category

Read more

06.11.23

Food Innovator Hero Bread™ Announces Series B Fundraise and National Retail Launch in 2,300 Stores

Read more